BRD4 and neoplasm: BRD4 regulates MYC to promote tumor growth in many tumor types (Ba et al., 2018), and BET inhibition by JQ1 and its analog (FT1101, CPI‐0610, etc.)has shown activity in clinical trials (NCT02543879, NCT02158858, etc).